NIST logo

Emerging Trends in Synthetic Drugs Workshop Presentation Slides

April 30, 2013

8:30 - 9:00 AM Registration
9:00 - 9:30 AM

WELCOME AND OPENING REMARKS

  • John Paul Jones II, Program Manager, Law Enforcement Standards Program (OLES), National Institute of Standards and Technology (NIST)
  • Jeff Comparin, Laboratory Director, Special Testing & Research Laboratory, Drug Enforcement Administration (DEA)
  • Scott Oulton, Chair of Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) & Associate Deputy Assistant Administrator, Office of Forensic Sciences, DEA
9:30 - 10:15 AM

EMERGING TRENDS IN SYNTHETIC CANNABINOIDS AND SUBSTITUTE CATHINONES

Overview of the Problem (Will Not Be Webcast or Captioned)

  • Bob Bell, Supervisory Special Agent, Office of Diversion Control, DEA
10:15 - 10:30 AM Break
10:30 - 11:45 AM

FEDERAL EMERGING TRENDS

Classes and Structures of Emerging Drugs

  • Arthur Berrier, PhD, Senior Research Chemist, Special Testing & Research Laboratory, DEA

Novel Hallucinogens and Plant-Derived Highs

  • Emily Dye, Forensic Chemist, Special Testing & Research Laboratory, DEA

Control Scheduling and Pending Legislation(Will Not Be Webcast or Captioned)

  • Terry Boos, Chemist, Office of Diversion Control, DEA

Moderated by Shannan Williams, Associate (Contractor), OLES, NIST

11:45 - 12:30 PM

INTERNATIONAL EMERGING TRENDS

New Drugs in the European Union

  • Andrew Cunningham, Scientific Analyst, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
12:30 - 1:45 PM Lunch
1:45 - 3:15 PM

STATE AND LOCAL EMERGING TRENDS - PART ONE

Synthetic Structures, State Legislation, Brand Names, Novel Approaches to Analysis, and How Analytical Results are Reported

3:15 - 3:30 PM Break
3:30 - 4:15 PM

PHARMACOLOGY OF SYNTHETIC DRUGS

  • Marilyn A. Huestis, PhD, Chief, Chemistry and Drug Metabolism, Clinical Pharmacology and Therapeutic Research Branch, National Institutes of Health Biomedical Research Center
4:15 - 5:00 PM

TOXICOLOGICAL ASPECTS OF SYNTHETIC DRUGS

  • Barry Logan, PhD, Executive Director, Center for Forensic Science Research and Education, National Medical Services

 May 1, 2013

8:30 - 9:00 AM Registration
9:00 - 9:20 AM

OPENING REMARKS AND CAPABILITIES FOR MEASUREMENTS, MATERIALS, DATA MODELING, AND INFORMATION PROCESSING IN THE CHEMICAL SCIENCES DIVISION

9:20 - 11:00 AM

IDENTIFICATION AND STANDARDS

Criteria for Identification of Synthetic Drugs

  • Scott Oulton, Chair of SWGDRUG & Associate Deputy Assistant Administrator, Office of Forensic Sciences, DEA

SWGDRUG Proposed Recommendation on Analogues and Structural Class Determinations 

  • Linda Jackson, Vice Chair of SWGDRUG & Director, Virginia Department of Forensic Science

Validation/Authentication of Physical Standards

  • Nicole Astor, Chemistry Technical Leader, Division of Forensic Sciences, Georgia Bureau of Investigation

Authentication of Physical Standards

  • Roxanne Franckowski, Senior Forensic Chemist, Special Testing & Research Laboratory, DEA

Moderated by John Paul Jones II, Program Manager, OLES, NIST

11:00 - 11:15 AM Break
11:15 - 12:30 PM

COLLABORATIVE EFFORTS

Live Demo of Online Database Resources for the Identification of Novel and Emerging Trends

  • Peter R. Stout, PhD, Senior Research Forensic Scientist, Research Triangle Institute (RTI) International

Advisory Committee for the Evaluation of Controlled Substances Analogs

  • Lindsay Reinhold, Forensic Chemist IV, National Medical Services

Moderated by Karen Phinney, Group Leader, Bioanalytical Science, NIST

12:30 - 1:30 PM Lunch
1:30 - 3:00 PM

STATE AND LOCAL EMERGING TRENDS - PART TWO

Synthetic Structures, State Legislation, Brand Names, Novel Approaches to Analysis, and How Analytical Results are Reported

Moderated by Shannan Williams, Associate (Contractor), OLES, NIST

3:00 - 3:15 PM Break
3:15 - 5:00 PM

LABORATORY ANALYTICAL TECHNIQUES

Color Tests and Analytical Difficulties with Emerging Drugs of Abuse

  • Jeremy Morris, Johnson County, Missouri Crime Laboratory 

Statistical Sampling Approaches for Synthetic Drugs

  • Jill Head, Supervisory Chemist, Special Testing & Research Laboratory,  DEA

Interpretation and Potential Pitfalls of Analysis

  • Josh Yohannan, Forensic Chemist, Special Testing & Research Laboratory, DEA

DEA Dosing Studies

  • Elizabeth Guest, PhD, Forensic Chemist, Special Testing & Research Laboratory, DEA

Moderated by William MacCrehan, Research Chemist, CSD, NIST

5:00 PM

CLOSING REMARKS

John Paul Jones II, Program Manager, OLES, NIST